We make them accessible.
It’s also the science.
From vision to reality: Panaxia and Neuraxpharm are the world’s first companies to sell medical cannabis extracts for inhalation in Europe
November 3, 2021 | Yahoo! This week, the first export of medical cannabis extracts for inhalation left Israel to Germany, the largest and fastest-growing medical cannabis
Panaxia continues growth: sums up 1st half of 2021 with 37.3 million revenues, 38.4% growth in comparison to 2020
September 2, 2021 | Yahoo! In the cumulative first six months of 2021, the company executed retail sales in Germany and Cyprus; Revenues of the 2nd
August 19, 2021 | Yahoo! The companies signed an agreement for the distribution of advanced medical cannabis-based products in Poland. First sales are expected during H1
July 29, 2021 | MarketWatch TEL AVIV, Israel and BIELEFELD, Germany, July 29, 2021 /PRNewswire via COMTEX/ — TEL AVIV, Israel and BIELEFELD, Germany, July 29,
Panaxia and Neuraxpharm To Exclusively Distribute Medical Cannabis Extracts For Inhalation In European Market
June 21 2021 | Benzinga by Jelena Martinovic Israel’s largest manufacturer and home-delivery distributor of medical cannabis products, Panaxia Labs Israel Ltd., and its German partner Neuraxpharm received the green
Panaxia Israel continues growth trend in the first quarter of 2021: reports record revenues of 19.7 million
May 31 2021 | Yahoo! 62% growth over the corresponding period the previous year and 16% over the previous quarter; The company is currently focused on